Virtus ETF Advisers’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-137,120
| Closed | -$302K | – | 407 |
|
|
2024
Q4 | $302K | Buy |
137,120
+23,942
| +21% | +$52.7K | 0.12% | 246 |
|
|
2024
Q3 | $187K | Hold |
113,178
| – | – | 0.09% | 283 |
|
|
2024
Q2 | $251K | Buy |
+113,178
| New | +$251K | 0.12% | 242 |
|
|
2021
Q4 | – | Sell |
-17,773
| Closed | -$214K | – | 386 |
|
|
2021
Q3 | $214K | Sell |
17,773
-1,625
| -8% | -$19.6K | 0.09% | 252 |
|
|
2021
Q2 | $410K | Sell |
19,398
-1,759
| -8% | -$37.2K | 0.17% | 191 |
|
|
2021
Q1 | $593K | Buy |
21,157
+581
| +3% | +$16.3K | 0.25% | 125 |
|
|
2020
Q4 | $535K | Buy |
20,576
+7,134
| +53% | +$185K | 0.22% | 137 |
|
|
2020
Q3 | $500K | Buy |
13,442
+1,132
| +9% | +$42.1K | 0.26% | 139 |
|
|
2020
Q2 | $632K | Buy |
12,310
+5,075
| +70% | +$261K | 0.3% | 104 |
|
|
2020
Q1 | $228K | Sell |
7,235
-1,063
| -13% | -$33.5K | 0.09% | 271 |
|
|
2019
Q4 | $495K | Buy |
8,298
+3,154
| +61% | +$188K | 0.08% | 204 |
|
|
2019
Q3 | $189K | Sell |
5,144
-286
| -5% | -$10.5K | 0.04% | 257 |
|
|
2019
Q2 | $253K | Sell |
5,430
-53
| -1% | -$2.47K | 0.05% | 272 |
|
|
2019
Q1 | $220K | Sell |
5,483
-796
| -13% | -$31.9K | 0.47% | 84 |
|
|
2018
Q4 | $289K | Sell |
6,279
-5,018
| -44% | -$231K | 0.05% | 124 |
|
|
2018
Q3 | $501K | Sell |
11,297
-8,187
| -42% | -$363K | 0.05% | 122 |
|
|
2018
Q2 | $764K | Buy |
19,484
+6,541
| +51% | +$256K | 0.68% | 56 |
|
|
2018
Q1 | $936K | Buy |
12,943
+6,886
| +114% | +$498K | 0.81% | 51 |
|
|
2017
Q4 | $399K | Sell |
6,057
-3,193
| -35% | -$210K | 0.5% | 53 |
|
|
2017
Q3 | $464K | Buy |
9,250
+846
| +10% | +$42.4K | 0.06% | 96 |
|
|
2017
Q2 | $389K | Sell |
8,404
-14,369
| -63% | -$665K | 0.06% | 78 |
|
|
2017
Q1 | $804K | Buy |
22,773
+2,183
| +11% | +$77.1K | 0.14% | 78 |
|
|
2016
Q4 | $258K | Buy |
20,590
+5,050
| +32% | +$63.3K | 0.08% | 132 |
|
|
2016
Q3 | $215K | Hold |
15,540
| – | – | 0.1% | 134 |
|
|
2016
Q2 | $154K | Buy |
15,540
+4,529
| +41% | +$44.9K | 0.11% | 140 |
|
|
2016
Q1 | $186K | Buy |
+11,011
| New | +$186K | 0.26% | 96 |
|